CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 2 of 17

Arthritis Research & Therapy

Briefs 41–80 of 641 CurrentRheuma has covered from this journal, newest publication first

Latest from Arthritis Research & Therapy

All coverage, newest first

  1. Arthritis Res Ther

    Factors associated with variations in the 6-minute walk distance during the follow-up of patients with systemic sclerosis

    Cohort studySystemic sclerosis

  2. Arthritis Res Ther

    Revisiting osteoarthritis as an inflammatory disease: characterization of synovitis grading and synovial pathotypes in surgical specimens

    Cross-sectional studyOsteoarthritis

  3. Arthritis Res Ther

    Clinical and MRI remission in axial spondyloarthritis: one-year outcomes and predictors from the TRACE treat-to-target study with secukinumab

    Cohort studySpondyloarthritis & PsA

  4. Arthritis Res Ther

    Ultrasound evaluation of muscle quality in rheumatoid arthritis: a reliability study of the Spanish Ultrasound Muscle Assessment in Rheumatoid Arthritis (SpUMAR) score

    Research articleRA

  5. Arthritis Res Ther

    Insights into axial spondyloarthritis features and the development of imaging evidence of sacroiliitis during long-term follow-up in routine clinical practice

    Cohort studySpondyloarthritis & PsA

  6. Arthritis Res Ther

    Interferon α-induced HERC6 provokes podocyte dysfunction via mitotic catastrophe in lupus nephritis

    Mechanistic studyLupus & APS

  7. Arthritis Res Ther

    Characteristics and safety outcomes of rheumatoid arthritis patients treated with AMGEVITA® in the United Kingdom using data from a national register

    Cohort studyRA

  8. Arthritis Res Ther

    Immunoglobulin G and plasma glycome in early rheumatoid arthritis differ from matched controls and link less fat-free mass to an accelerated aging phenotype: an exploratory study

    Cohort studyRA

  9. Arthritis Res Ther

    Cellular and molecular landscapes of inflammation in anterior cruciate ligament rupture patients are independent on concurrent meniscal injury

    Cross-sectional studyOsteoarthritis

  10. Arthritis Res Ther

    Defining pain trajectories in juvenile arthritis and associated patient characteristics

    Cohort studyPediatric

  11. Arthritis Res Ther

    Serum citrullinated histone H3 as a biomarker of disease activity and renal outcome in microscopic polyangiitis and granulomatosis with polyangiitis

    Cohort studyVasculitis & PMR

  12. Arthritis Res Ther

    The DHCQ/HCQ metabolic ratio and CYP2C8 Genotype are associated with lipid profile improvement in systemic lupus erythematosus patients treated with hydroxychloroquine

    Cohort studyLupus & APS

  13. Arthritis Res Ther

    Development and preliminary evaluation of a measure ofself-efficacy of Self-Management in ARThritis: SMART

    Secondary analysisAcross diseases

  14. Arthritis Res Ther

    No major effect of age (< 40 vs. ≥ 40 years) on response to secukinumab in patients with axSpA: a post hoc analysis of six phase 3 trials

    Meta-analysisSpondyloarthritis & PsA

  15. Arthritis Res Ther

    Inflammation-related composite indices and their association with osteoporosis and fragility fractures in rheumatoid arthritis

    Cross-sectional studyOsteoporosis

  16. Arthritis Res Ther

    RBP4—a risk factor in lipid metabolism—serves as an early diagnostic and prognostic marker of knee osteoarthritis progression

    Case-control studyOsteoarthritis

  17. Arthritis Res Ther

    Plasma exosomal fibroblast activation protein: a novel biomarker links fatty acid metabolic dysregulation to systemic lupus erythematosus

    Mechanistic studyLupus & APS

  18. Arthritis Res Ther

    Color Doppler carotid resistance, pulsatility, and aortic oscillometry indices in giant cell arteritis: insights from the VASCARD cohort

    Cross-sectional studyVasculitis & PMR

  19. Arthritis Res Ther

    Work productivity and activity impairment in patients under 18 with juvenile idiopathic arthritis (JIA): the international UCAN CAN-DU prospective study

    Cohort studyPediatric

  20. Arthritis Res Ther

    Immunological and clinical predicators for venous thromboembolism in ANCA-associated vasculitis patients: elevated natural killer cells and cardiac involvement

    Cohort studyVasculitis & PMR

  21. Arthritis Res Ther

    The association between methotrexate metabolism-related gene polymorphisms and therapeutic efficacy and toxicity in patients with rheumatoid arthritis

    Research articleRA

  22. Arthritis Res Ther

    Risk of serious infections, myocardial infarction or stroke, venous thromboembolic events, and malignancy in patients with psoriatic arthritis treated with tofacitinib compared with biologic treatments in the United States

    Cohort studySpondyloarthritis & PsA

  23. Arthritis Res Ther

    Beyond glomeruli: interstitial fibrosis and tubular atrophy predict poor renal outcomes in lupus nephritis

    Cohort studyLupus & APS

  24. Arthritis Res Ther

    Serum epitope-specific anti-recoverin autoantibodies as biomarkers for lupus retinopathy

    Diagnostic or prognostic studyLupus & APS

  25. Arthritis Res Ther

    Methylprednisolone pulses are associated with faster remission in Giant Cell Arteritis: a multicentre inception cohort study

    Cohort studyVasculitis & PMR

  26. Arthritis Res Ther

    Characteristics of CLA⁺Tregs in rheumatoid arthritis and their potential as biomarkers of treatment response

    Case-control studyRA

  27. Arthritis Res Ther

    Treatment patterns, treat-to-target goals and clinical outcomes of patients with active lupus nephritis: real-world evidence from a multicentre cohort study

    Cohort studyLupus & APS

  28. Arthritis Res Ther

    Increased soluble CD200 in serum of SLE patients does not reflect disease activity or affect CD200R1 function in T cells

    Cross-sectional studyLupus & APS

  29. Arthritis Res Ther

    Identification of candidate biomarkers for diagnosis, disease activity, and relapse prediction in IgG4-related disease

    Diagnostic or prognostic studyAutoinflammatory & rare

  30. Arthritis Res Ther

    Predicting clinical response in psoriatic arthritis through integrative analysis of transcriptomics and proteomics

    Secondary analysisSpondyloarthritis & PsA

  31. Arthritis Res Ther

    Predictors of glucocorticoid-free clinical remission in patients with newly diagnosed microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study using a nationwide registry in Japan (J-CANVAS)

    Cohort studyVasculitis & PMR

  32. Arthritis Res Ther

    Soluble factors released from fibroblast-like synoviocytes of JIA patients with future extended course can condition persistent JIA synovial fibroblasts for increased IL-6 production

    Mechanistic studyPediatric

  33. Arthritis Res Ther

    Development and validation of a risk score for serious infection in patients with rheumatic diseases receiving prolonged high-dose glucocorticoids

    Diagnostic or prognostic studyAcross diseases

  34. Arthritis Res Ther

    An interpretable machine learning model integrating clinical and ct radiomic features for the detection of interstitial lung disease in idiopathic inflammatory myopathies

    Diagnostic or prognostic studyMyositis

  35. Arthritis Res Ther

    Sleep quality, duration, and multi-trajectories as predictors of rheumatoid arthritis: evidence from the english longitudinal study of ageing

    Cohort studyRA

  36. Arthritis Res Ther

    Upadacitinib for refractory Behcet’s syndrome: a multi-centre, single-arm trial

    Research articleVasculitis & PMR

  37. Arthritis Res Ther

    Risk factors of serious infections in patients with large-vessel vasculitis after the approval of tocilizumab in 2017: a retrospective nested case-control study using the Japanese health insurance database

    Case-control studyVasculitis & PMR

  38. Arthritis Res Ther

    Synovial fluid potentiates local fibroblasts to drive monocyte activation in juvenile idiopathic arthritis

    Mechanistic studyPediatric

  39. Arthritis Res Ther

    Sleep improvement in patients with rheumatoid arthritis treated with upadacitinib in real-world practice: results from the SLEERA study

    Cohort studyRA

  40. Arthritis Res Ther

    Regional differences in clinical manifestations of antisynthetase syndrome: a comparison between Asian and European cohorts

    Cohort studyMyositis

All 641 Briefs in ExploreShowing Briefs 41–80 of 641, newest first